A new therapy for influenza virus infections that may also prove effective against many other pathogenic virus infections, including HIV and COVID-19, has been developed by scientists.
In an average year, more than 2 million people in the United States are hospitalized with the flu, and 30,000 to 80,000 of them die from the flu or related complications.
The team's work is detailed in Nature Communications and uses a targeted therapy approach against the virus infections.
"We target all of the antiviral drugs we develop specifically to virus-infected cells," said the senior author. "That way, we treat the diseased cells without harming healthy cells. We use this capability to deliver immune-activating drugs selectively into flu-infected cells. There is also the potential that this therapy will prove efficacious in people infected with COVID-19."
The flu virus, like many other pathogenic viruses, exports its proteins into its host cell surface and then buds off nascent viruses in the process of spreading to adjacent host cells. Because these exported viral proteins are not present in the membranes of healthy host cells, the team has exploited the presence of viral proteins in infected cells by designing homing molecules that target drugs specifically to virus-infected cells, thereby avoiding the collateral toxicity that occurs when antiviral drugs are taken up by uninfected cells.
The authors designed and synthesized a bifunctional small molecule by conjugating the neuraminidase inhibitor, zanamivir, with the highly immunogenic hapten, dinitrophenyl (DNP), which specifically targets the surface of free virus and viral-infected cells.
They show that this leads to simultaneous inhibition of virus release, and immune-mediated elimination of both free virus and virus-infected cells. Intranasal or intraperitoneal administration of a single dose of drug to mice infected with 100x MLD50 virus is shown to eradicate advanced infections from representative strains of both influenza A and B viruses. Since treatments of severe infections remain effective up to three days post lethal inoculation, the approach may successfully treat infections refractory to current therapies.
"We chose to start our tests with influenza virus because the results can often be applied to other enveloped viruses," the author said. "Our lab tests show that our process works in influenza infected mice that are inoculated with 100 times the lethal dose of virus."
The author said the new therapy may prove effective against other pathogenic virus infections such as hepatitis B, HIV and respiratory syncytial virus (RSV).
https://www.purdue.edu/newsroom/releases/2020/Q4/new-therapy-for-flu-may-help-in-fight-against-covid-19.html
https://www.nature.com/articles/s41467-020-19386-5
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fa-universal-dual&filter=22
A universal dual mechanism immunotherapy for the treatment of influenza virus infections
- 1,496 views
- Added
Edited
Latest News
Active biointegrated living…
By newseditor
Posted 17 Jun
Which of the two DNA strand…
By newseditor
Posted 16 Jun
Microglia depletion prevent…
By newseditor
Posted 16 Jun
Colorectal cancer stem cell…
By newseditor
Posted 16 Jun
Paranoia in the brain
By newseditor
Posted 16 Jun
Other Top Stories
Taking Vitamin D May Benefit People with Multiple Sclerosis
Read more
RNAs inherited from your father?
Read more
Role of nervous system in anaphylaxis
Read more
Sugar in Western diets increases risk for breast cancer tumors and…
Read more
Eating when we are not hungry is bad for our health
Read more
Protocols
Bioengineered human colon o…
By newseditor
Posted 14 Jun
Development of an efficient…
By newseditor
Posted 12 Jun
A co-culture system of macr…
By newseditor
Posted 10 Jun
Analysis of 3D pathology sa…
By newseditor
Posted 08 Jun
Long-term expandable mouse…
By newseditor
Posted 07 Jun
Publications
Microbiome-derived acidity…
By newseditor
Posted 17 Jun
The Thermodynamics of Mind
By newseditor
Posted 17 Jun
Lost in translation: challe…
By newseditor
Posted 17 Jun
Pathways for macrophage upt…
By newseditor
Posted 16 Jun
Common and distinct neural…
By newseditor
Posted 16 Jun
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar